LONDON–(BUSINESS WIRE)–Citi, acting through Citibank N.A., has been appointed by Stealth BioTherapeutics Corp. (“Stealth”) as depositary bank for its American Depositary Receipt (“ADR”) programme. Stealth’s ADRs trade on the Nasdaq Global Market under the symbol “MITO.” Each ADR represents 12 ordinary shares of Stealth. “We are pleased to have been selected by Stealth as depositary bank for its Nasdaq listed ADR programme,” said Dirk Jones, Global Head of Issuer Services, at Citi. “We look fo

Source link